Herbert, A. A., Glaab, D., & Schreiber, R. (2020). A Multicenter, Open Label, Phase 1 Study of the Safety, Tolerability, Systemic Exposure, Pharmacodynamics, and Treatment Effect of Calcipotriene Foam, 0.005% in Pediatric Subjects (Ages 2 to 11 Years) with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, 4(5), s35. https://doi.org/10.25251/skin.4.supp.35